Get Updates

Making Sense of Cancer Headlines

FORCE's XRAYS program, funded by the CDC, is a reliable resource for young breast cancer survivors and high-risk women to navigate through breast cancer research related news and information.

XRAYS logo and women

XRAYS - Making Sense of Cancer Headlines

Be a part of XRAYS

XRAYS: Making Sense of Cancer Headlines


About the XRAYS Program

FORCE developed our eXamining the Relevance of Articles for Young Survivors (XRAYS) program to empower young breast cancer survivors and high-risk women by providing tools for evaluating reports of new breast cancer-related research. Funded by the CDC, XRAYS will provide reviews and ratings of news media articles on breast cancer research to help young breast cancer survivors better understand research that is relevant to them. Learn more about the XRAYS program

 

Featured Studies and Articles

XRAYS Rating

STUDY: Women with breast cancer symptoms but no lump may wait longer to seek medical care

Some patients take longer than others before getting a potential breast cancer checked by their health care provider. Believing that women who have breast cancer symptoms but have no lump may wait longer, researchers in this study used data from women who were diagnosed with breast cancer in 2009 and 2010 to identify possible explanations. (1/18/17)

XRAYS Rating

STUDY: High vitamin D levels at breast cancer diagnosis may be associated with a better prognosis

Vitamin D is most known for its role in maintaining bone health. Recent research looked at its role in many other biological processes and diseases, including breast cancer. In this study, researchers found that breast cancer patients who had the highest amounts of vitamin D in their blood (slightly over the recommended levels) had better health outcomes, including overall survival, than women with lower amounts of vitamin D. This finding adds to the growing evidence for the role of vitamin D in cancer, but it does not change how breast cancer is prevented or treated. (1/10/17)

XRAYS Rating

STUDY: Angelina Jolie spoke out on BRCA testing: Did genetic testing increase?

Angelina Jolie published an editorial in the New York Times in 2013 about her choice to have a double mastectomy after finding out she was positive for a BRCA1 mutation. Researchers from a recent study claim that her celebrity endorsement of BRCA testing may have missed its target audience (previvors), due to the increase in BRCA testing following publication of the editorial but a decrease in the number of mastectomies performed. However, the study failed to take into account that many women without breast cancer do not pursue mastectomy in the months following genetic testing. (1/4/17)

XRAYS Rating

ARTICLE: Male transgender breast cancer patient shares his experience in NYT piece

Denise Grady’s New York Times piece presents the struggles faced by Eli Oberman, a male transgender patient who was diagnosed with breast cancer, including the difficulty of being the only male patient in gynecologist waiting rooms that are full of women. (12/21/16)

View all XRAYS articles and reviews

Find older XRAYS studies and articles

By keyword search:

By date range:

By quarterly digest:

FORCE:Facing Our Risk of Cancer Empowered